EVA JOSEPH: Open Payments
NPI 1346614898 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 115 payments from 29 companies in 2025. Trend: 2023 $1,601 · 2024 $2,810 · 2025 $2,106
Food & beverage: $2,006Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $340 |
| PFIZER INC. | 13 | $196 |
| Novartis Pharmaceuticals Corporation | 9 | $167 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Astellas Pharma US Inc | 3 | $102 |
| Incyte Corporation | 5 | $101 |
| Pharmacosmos Therapeutics Inc. | 5 | $99 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Daiichi Sankyo Inc. | 5 | $87 |
Products named: RYBREVANT, DARZALEX, KISQALI, IBRANCE, Vyloy, MONOFERRIC, KEYTRUDA, REBLOZYL.
Industry payments across KY — which companies pay providers there.
